HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer
Sherry Shen, Weining Ma, David N. Brown, Arnaud Da Cruz Paula, Qin Zhou, Alexia Iaosonos, Basile Tessier‐Cloutier, Dara S. Ross, Tiffany A. Troso-Sandoval, Jorge S. Reis‐Filho, Nadeem R. Abu‐Rustum, Yanming Zhang, Lora H. Ellenson, Britta Weigelt, Vicky Makker, M. Herman Chui
Topics & Concepts
TrastuzumabImmunohistochemistryMedicineFluorescence in situ hybridizationOncologyPathologyBreast cancerTargeted therapyAdjuvant therapyInternal medicineSerous fluidClinical significanceCancerCancer researchBiologyGeneChromosomeBiochemistryHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchCell Adhesion Molecules Research